logo

Sector: Pharmaceuticals & Biotechnology

|

Small Cap

Goldline Pharmaceutical Share Price

GLPL

₹32.50

0.00(0.00%)
NSE :

Open Free Demat Account

Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Goldline Pharmaceutical Share Price Today

As of 12-10-2026 18:14, Goldline Pharmaceutical Ltd. share price today is ₹0, with a change of ₹-32.50 (-100.00%) from the previous close of ₹32.5. The stock opened at ₹32.5 and traded between ₹32.5 and ₹32.5, with a total traded volume of 6000 shares. The company has a market capitalization of ₹31.7 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹60 and ₹28.5, respectively.

Goldline Pharmaceutical Ltd. valuation metrics include a P/E ratio of 7.7, and book value of ₹2.40. Profitability indicators show ROE of 33.08%.

Goldline Pharmaceutical Ltd. technical indicators include Day RSI at 42.19, Day MFI at 46.61, Day ADX at 30.87. Additional indicators include Commodity Channel Index (CCI) at -45.9 and Williams %R at -44.4. Momentum indicators show Day MACD at -1.98, Day MACD Signal Line at -2.02, DayATR at 2.15. Rate of Change indicators for Goldline Pharmaceutical Ltd. include ROC21 at -17.5.

Exponential moving averages include EMA5 at ₹32.5, EMA10 at ₹32.8, EMA12 at ₹33.1, EMA20 at ₹34.3, EMA26 at ₹35.1, EMA50 at ₹37.6. Simple moving averages include SMA5 at ₹31.8, SMA10 at ₹32.2, SMA20 at ₹34.6, SMA30 at ₹36.5, SMA50 at ₹37.9.

Support levels for Goldline Pharmaceutical are placed at First Support ₹32.35, Second Support ₹31.69, Third Support ₹31.37. Resistance levels are seen at First Resistance ₹33.33, Second Resistance ₹33.65, Third Resistance ₹34.31. Goldline Pharmaceutical Ltd. shareholding pattern shows promoter holding at 57.29%, FII holding at 5.16%, DII holding at 0%, public holding at 29.74%.

Goldline Pharmaceutical Performance

Price Movement

N/A

₹32.50

₹32.50

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹32.50
Low₹32.50
Open at₹32.50
Prev Close₹32.50
Volumes6.00 K
Avg Price₹32.50
Lower Circuit₹26.00
Upper Circuit₹39.00

Historical Performance

3M High₹45.99
3M Low₹28.50
1 Yr High₹60.00
1 Yr Low₹28.50
3 Yr High₹60.00
3 Yr Low₹28.50
5 Yr High₹60.00
5 Yr Low₹28.50

Goldline Pharmaceutical Fundamentals

Market Cap
Low in industry
31.70 Cr.
PE Ratio (TTM)
Low in industry
7.70
Dividend Yield
0
Net Profit TTM
Net profit TTM
-
Net Profit Growth
Net profit TTM
-
PEG Ratio
-
ROE
0% decr over last year
33.08
Operating Revenue TTM
-
Operating Revenue Growth
Operating Revenue TTM
Book Value
Below industry Median
2.40
MFI
MFI is mid-range
46.61
RSI
RSI is mid-range
42.19
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
2.40

Goldline Pharmaceutical Financials

Data not available for chart

Indicator
No Record Found

Goldline Pharmaceutical Technicals

Goldline Pharmaceutical Ltd. EMA & SMA

₹32.50

-1.46 (-4.30%)

↗ Bullish Moving Average

4

↘ Bearish Moving Average

7

Day EMA5 ₹32.5
Day EMA10 ₹32.8
Day EMA12 ₹33.1
Day EMA20 ₹34.3
Day EMA26 ₹35.1
Day EMA50 ₹37.6
-
-

Goldline Pharmaceutical Support and Resistance

Resistance

First Resistance₹33.33
Second Resistance₹33.65
Third Resistance₹34.31

Support

First Support₹32.35
Second Support₹31.69
Third Support₹31.37

Technical Indicators

Day RSI42.19
Day MFI46.61
Day ADX30.87
Day Commodity Channel Index-45.90
William-44.40
Day MACD-1.98
Day MACD Signal Line-2.02
Day ATR2.15
Day ROC125-
Day ROC21-17.50

Goldline Pharmaceutical Shareholding Pattern

Held By
Promoter
FII
DII
Public

Goldline Pharmaceutical Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day6 K9 K66.67%
Week27 K34.5 K78.26%
1 Month21.75 K29.63 K73.42%
6 Month57 K71.86 K79.33%

Goldline Pharmaceutical SWOT Analysis

Strengths9
Weakness7
Opportunity0
Threats0

MACD Crossover Above Signal Line

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

MACD crossed above signal line previous end of day

Goldline Pharmaceutical Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
No Record Found

Goldline Pharmaceutical Stock Comparison

Financials
Price (₹)₹112.65₹150₹504.05₹168.45₹290
% Change-3.43%-1.96%2.06%-0.03%0.00%
Revenue TTM (₹ Cr)--₹526.28--
Net Profit TTM (₹ Cr)--₹20.77--
PE TTM14.6016.40106.5012.8043.30
1 Year Return11.5127.67
ROCE-34.193.56--
Summarize with AI
Google GeminiChatGPTPerplexity AIAnthropic AIGrok AI

FAQ's on GLPL

Desktop BannerMobile Banner

Invest Anytime, Anywhere

Get it on Google PlayGet it on App Store

Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy